Olink

Olink®
Part of Thermo Fisher Scientific

Shared genetic architecture contributes to risk of major cardiovascular diseases

Nature Communications, 2025

Qiao J., Jiang L., Cai L., Chang M., Wang C., Zhao R., Song S., Zhao Y., Chen M., Ding S., Tan N., He P., Sadayappan S., Xu J., Pauklin S., Liu Z., Feng Y.

Disease areaApplication areaSample typeProducts
CVD
Pathophysiology
Plasma
Olink Explore 3072/384

Olink Explore 3072/384

Abstract

The extensive co-occurrence of cardiovascular diseases (CVDs), as evidenced by epidemiological studies, is supported by positive genetic correlations identified in comprehensive genetic investigations, suggesting a shared genetic basis. However, the precise genetic mechanisms underlying these associations remain elusive. By assessing genetic correlations, genetic overlap, and causal connections, we aim to shed light on common genetic underpinnings among major CVDs. Employing multi-trait analysis, we pursue diverse strategies to unveil shared genetic elements, encompassing SNPs, genes, gene sets, and functional categories with pleiotropic implications. Our study systematically quantifies genetic overlap beyond genome-wide genetic correlations across CVDs, while identifying a putative causal relationship between coronary artery disease (CAD) and heart failure (HF). We then pinpointed 38 genomic loci with pleiotropic influence across CVDs, of which the most influential pleiotropic locus is located at the LPA gene. Notably, 12 loci present high evidence of multi-trait colocalization and display congruent directional effects. Examination of genes and gene sets linked to these loci unveiled robust associations with circulatory system development processes. Intriguingly, distinct patterns predominantly driven by atrial fibrillation, coronary artery disease, and venous thromboembolism underscore the significant disparities between clinically defined CVD classifications and underlying shared biological mechanisms, according to functional annotation findings.

Read publication ↗